The Market For Diabetes Drugs, Devices, And Disease Management


May 1, 1996
214 Pages - SKU: AA483
Attention: There is an updated edition available for this report.
License type:
Table of Contents Search inside this report Related Reports
Countries covered: United States

The Market For Diabetes Drugs, Devices, And Disease Management

  enlarge
Now 50% off the original sale price of $3,250.
Every year, 23% of total pharmacy sales are made to diabetes. This report on diabetes management analyzes the market for diabetes drug therapies and home glucose testing. Provides market estimates for 1990-1995 and forecasts through 2000. Examines newly approved drug therapies such as Bristol-Myers Squibb's Glucophage (metformin), home monitoring, and disease management programs. Describes pharmaceutical therapies in development for the treatment of diabetes or the reduction of complications--and their development stages. Covers novel formulations, delivery systems, monitoring products, generic competition, and managed care. Profiles competitors including Eli Lilly, Pfizer, and Warner-Lambert.



More Drug Delivery reports by Kalorama Information

The World Market for Implantable and Needle-Free Drug Delivery Systems by Kalorama Information
This report, The World Market for Implantable and Needle-Free Drug Delivery details the types of drug delivery systems and technologies that are being used in ...
The World Market for Transdermal Drug Delivery by Kalorama Information
Transdermal (and related transmucosal)  drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. There is no potential limit for the ...
Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market by Kalorama Information
The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if ...
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics by Kalorama Information
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and ...
See all reports like this >>

More United States Drug Delivery reports

Nanotechnology Drug Delivery Market in the US 2012-2016 by Infiniti Research Limited
TechNavio's analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of ...
The 2013-2018 Outlook for Pulmonary Drug Delivery Systems in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for pulmonary drug delivery systems across the states and cities of the United States. Latent demand (in ...
The 2013-2018 Outlook for Oral Drug Delivery Systems in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for oral drug delivery systems across the states and cities of the United States. Latent demand (in ...
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery by Frost & Sullivan
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In Oncology, developers are interested in understanding the opportunities and ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Drug Delivery Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!